OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
June 03, 2022
Astellas and GO Therapeutics will work together to develop novel antibodies for immuno-oncology.
Thermo Fisher Scientific and Qatar Genome Program will use custom genotyping arrays to accelerate genomic research in Qatar.
PMS moves its headquarters to Boulder Technology Center in Niwot, Col.
Cambrex’s acquisition of Q1 Scientific expands the company’s storage services in the European market.
Industry experts discuss the need for stricter environmental controls, whether to incorporate single-use technologies, and areas for improved automation.
This article describes the in-vitro permeation test study data processing procedures and FDA statistical mathematics of evaluating a generic topical drug product, acyclovir cream, against its reference product.
Putting the patient at the forefront of drug development is essential, particularly to ensure medication compliance is optimized.
The right processes used with the right excipient combinations address evolving formulation needs.
Collecting relevant data, planning ahead, and communicating with regulatory bodies in pre-IND meeting programs can help companies to avoid roadblocks in IND applications.
June 02, 2022
Analyzing elemental impurities in drug products is—much like other analytical testing—primarily aimed at ensuring patient safety.